Table 1.

Classification of the eight studied groups based on their genotype, exposure and antileukinate treatment

Group:	1	2	3	4	5	6	7	8
WT	+	-	+	-	+	-	+	-
Tg	-	+	-	+	-	+	-	+
21% (RA)	+	+	-	-	+	+	-	-
95% O2 (H)	-	-	+	+	-	-	+	+
Antileukinate	-	-	-	-	+	+	+	+